α-Synuclein structure, posttranslational modification and alternative splicing as aggregation enhancers

Abstract

Alpha-synuclein aggregation is thought to be a key event in the pathogenesis of synucleinopathies. Although different alpha-synuclein alterations and modifications have been proposed to be responsible for early aggregation steps, the mechanisms underlying these events remain unclarified. Alpha-synuclein is a small protein localized to synaptic terminals and its intrinsic structure has been claimed to be an important factor for self-oligomerization and self-aggregation. Alpha-synuclein expression studies in cell cultures have demonstrated that posttranslational modifications, such as phosphorylation, oxidation, and sumoylation, are primarily involved in alpha-synuclein aggregation. Furthermore, in the last few years accumulating evidence has pointed to alternative splicing as a crucial mechanism in the development of neurodegenerative disorders. At least three different alpha-synuclein isoforms have been described as products of alternative splicing. Two of these isoforms (alpha-synuclein 112 and alpha-synuclein 126) are shorter proteins with probably altered functions and aggregation propensity. The present review attempts to summarize the data so far available on alpha-synuclein structure, posttranslational modifications, and alternative splicing as possible enhancers of aggregation.

The Molecular Chaperone Hsp90 Modulates Intermediate Steps of Amyloid Assembly of the Parkinson-related Protein α-Synuclein

“…The physiological function of AS is still elusive (3,4). Research is mainly focused on the etiology of a series of neurologic disorders known as synucleinopathies, first among them is Parkinson disease.…”

Modeling of molecular processes underlying Parkinson’s disease in cells of methylotrophic yeast Hansenula polymorpha

“…This difference could be explained by alternative splicing of SNCA transcript, which results in formation of two differently sized mRNAs of 339 and 420 bps in length. It is known that at least three isoforms of α-syn are produced via alternative splicing [3]. The major form of the protein, and the one most investigated, is the 140 aminoacids-long transcript.…”

Camelid single-domain antibody fragments: Uses and prospects to investigate protein misfolding and aggregation, and to treat diseases associated with these phenomena

“…A recent study has, however, suggested that it might form, in the cell, a dynamic tetramer that is not prone to aggregation [107]. Three regions can be distinguished in the aSyn sequence [106,108] ( Fig. 5A).…”

“…5A), and the triplication of the aSyn gene are correlated with early onset of the disease [105]. Extensive experimental data indicate that aSyn belongs to the family of natively unfolded proteins, characterised by a lack of typical secondary structures and thus of tightly packed tertiary structure [106]. A recent study has, however, suggested that it might form, in the cell, a dynamic tetramer that is not prone to aggregation [107].…”